Funder: National Institutes of Health
Due Dates: December 1, 2026 (Estimated, forecasted)
Funding Amounts: Expected 3 awards; award size and total program funding not yet specified; cooperative agreement
Summary: Supports clinical centers to test and optimize anti-obesity medication strategies for children and adolescents, focusing on maximizing benefits and minimizing risks.
Key Information: This is a forecasted opportunity; dates and details may change—check the program page for updates.